微生物共生因子は,腸内炎症疾患を予防する
Sarkis K Mazmanian1, June L Round, Dennis L Kasper
1Division of Biology, California Institute of Technology, Pasadena, California 91125, USA. sarkis@caltech.edu
Nature
|May 30, 2008
まとめ
Bacteroides fragilisからの細菌分子ポリサッカリドA (PSA) は,炎症性サイトカインを抑制することによって大腸炎を予防します. この発見は,微生物の分子を強調しています.
科学分野:
- マイクロバイオームの研究
- 免疫学 免疫学とは
- 胃腸内科 胃腸内科
背景:
- 人間の腸は,様々な微生物を宿し,不均衡 (ディスバイオシス) が炎症性腸疾患に関連している.
- コメンサルバクテリアは有益または病原性であり,宿主の健康に影響を与える可能性があります.
- ホストと微生物の相互作用を理解することは,腸疾患の管理に不可欠です.
研究 の 目的:
- 実験的な大腸炎に対するBacteroides fragilisの保護的役割を調査する.
- この保護効果に起因する特定の微生物要因を特定する.
- この宿主-微生物の相互作用の基礎にある免疫調節メカニズムを解明する.
主な方法:
- ヘリコバクターヘパチカスを用いた動物モデルでの実験的な大腸炎の誘導.
- 野生型およびポリサッカリドA (PSA) 欠乏のバクテロイド・フレジリス菌株を使用しています.
- 浄化されたPSAの投与と免疫細胞応答の評価 (例えば,サイトカイン生成,T細胞集団など).
主要な成果:
- PSAが欠けているBacteroides fragilisは,H. hepaticusが誘発した大腸炎から保護できませんでした.
- 浄化されたPSAは,腸内免疫細胞による炎症誘発性サイトカイン (インターリューキン-17) の生成を抑制した.
- 必要なPSA介護は,インタールイキン10を産生するCD4+T細胞である.
結論:
- PSAのような細菌分子は,腸の健康を維持し,炎症を予防する上で重要な役割を果たします.
- PSAは,IL-10を生成するT細胞を通じて免疫反応を調節することによって,その保護効果を発揮する.
- PSAのような微生物共生因子をターゲットにすることは,炎症性疾患の潜在的な治療戦略を提供します.
さらに関連する動画
関連する概念動画
01:17Irritable Bowel Syndrome I: Introduction
1.4K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.4K
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
1.5K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K
01:30Inflammatory Bowel Disease II: Crohn's Disease
1.6K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
1.1K
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K
01:29Inflammatory Bowel Disease IV: Pharmacological Management
976
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
976
01:18Functions of the Gut Microbiota
78
The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
78